GPHN rs121908539: What Your Genotype Means
The rs121908539 variant is a rare genetic change located within the GPHN gene. It is classified as a pathogenic variant associated with hereditary hyperekplexia, a neurological condition characterized by an exaggerated startle response.
What each genotype means
Typical gephyrin function
This is the common, wild-type genotype for this position in the GPHN gene. It is not associated with the hereditary hyperekplexia reported in clinical literature for this variant.
This is the most common genotype found in the general population.
Carrier of rare variant
This genotype indicates you carry one copy of the T allele, which has been identified in individuals with hereditary hyperekplexia. The clinical significance of this specific change remains uncertain, as research suggests it does not disrupt known protein interactions or structural lattices of the gephyrin protein.
This genotype is very rare in the general population.
Rare variant genotype
This genotype indicates you carry two copies of the T allele, which is classified as pathogenic in some clinical databases in the context of hereditary hyperekplexia. However, because the functional impact of this specific variant is not fully understood and it does not appear to disrupt standard gephyrin protein structures, its clinical implications remain a subject of ongoing research.
This genotype is extremely rare and is not typically observed in large-scale population studies.
Understanding the Variant and Its Location
The variant rs121908539 is a specific change in the human genetic code located on chromosome 14. In the context of the GPHN gene, this variant represents a single nucleotide substitution. Genetic variants like this are identified by their unique reference SNP ID (rsID) assigned by the dbSNP database, which serves as a catalog for human genetic variation. Because this variant is located within a gene that plays a critical role in neurotransmission, researchers monitor its presence to understand how it might alter the function of the resulting protein. It is important to note that the presence of a variant does not automatically imply a clinical diagnosis, as genetic testing results must always be interpreted by qualified medical professionals in the context of an individual's overall health and clinical symptoms.
The Role of the GPHN Gene
The GPHN gene provides instructions for producing a protein called gephyrin. Gephyrin is essential for the proper functioning of the nervous system, specifically acting as a scaffolding protein that clusters glycine receptors at inhibitory synapses. These synapses are responsible for dampening or stopping nerve signals, which is vital for controlling muscle tone and preventing over-excitation in the brain and spinal cord. When the GPHN gene is altered, the gephyrin protein may not function correctly, potentially leading to a disruption in how neurons communicate. This disruption is a known mechanism in several neurological disorders, as the inability to properly regulate inhibitory signals can lead to the hyperexcitability observed in conditions like hereditary hyperekplexia.
Research and Clinical Associations
Research has linked pathogenic variants in the GPHN gene to hereditary hyperekplexia, a rare disorder often identified in newborns. This condition is characterized by an excessive startle response to unexpected stimuli, such as a tap on the nose, and can involve generalized muscle stiffness. While mutations in other genes like GLRA1 and SLC6A5 are more commonly associated with this condition, GPHN is recognized as a contributing factor in a smaller subset of cases. The evidence for the pathogenicity of rs121908539 is supported by clinical databases such as ClinVar, which categorize it as pathogenic based on its association with this neurological disorder. Because this is a rare condition, the scientific understanding of how specific GPHN variants influence disease severity is still evolving, and clinical findings can vary significantly between individuals.
Population Frequency and Interpretation
The rs121908539 variant is considered very rare in the general population. Because it is not a common polymorphism, it is not typically found in large-scale population screening studies at high frequencies. When a variant is this rare, it is often identified through clinical genetic testing of individuals who are already exhibiting symptoms of a specific disorder. For the general public, the likelihood of carrying this variant is extremely low. If an individual receives a report indicating the presence of this variant, it is essential to consult with a genetic counselor or a medical specialist. They can provide context regarding the significance of the finding, discuss the necessity of confirmatory testing, and explain what the results mean for the individual or their family members.
What You Can Do With This Information
Genetic information is a tool for understanding biological predispositions, but it is not a substitute for a clinical evaluation. If you or a family member have concerns about symptoms related to hyperekplexia, such as an exaggerated startle reflex or muscle stiffness, the most important step is to seek an evaluation from a neurologist or a clinical geneticist. These professionals can perform appropriate diagnostic tests, such as physical examinations or targeted genetic sequencing, to determine the cause of the symptoms. You should never use genetic data to self-diagnose or make medical decisions without professional guidance. Always discuss any findings from genetic reports with your healthcare provider, who can help you navigate the complexities of your results and determine if any further action is required.
How common is this variant?
The rs121908539 variant is classified as very rare across all major human populations.
Frequently asked questions
What is hereditary hyperekplexia?
Hereditary hyperekplexia is a rare neurological disorder characterized by an exaggerated startle response to unexpected stimuli. It is often observed in newborns and can cause temporary muscle stiffness or hypertonia.
Is GPHN the only gene linked to hyperekplexia?
No, hyperekplexia is genetically heterogeneous, meaning it can be caused by mutations in several different genes. Other genes involved include GLRA1, SLC6A5, GLRB, and ARHGEF9.
Does having the rs121908539 variant mean I have a disease?
Not necessarily. While this variant is classified as pathogenic, genetic testing results must be interpreted by a doctor in the context of your clinical symptoms and family history. Always consult a medical professional to understand the implications of your specific genetic results.
How is hyperekplexia diagnosed?
Diagnosis typically involves a clinical evaluation by a neurologist, which may include a physical exam, observation of the startle response, and molecular genetic testing to identify mutations in known disease-associated genes.
Where can I find more information about GPHN?
You can find reliable information about the GPHN gene and its associated variants through resources like the NCBI Gene database, ClinVar, and MedlinePlus Genetics. These sites provide curated, evidence-based information for both researchers and the public.
Sources & further reading
Educational information only, last refreshed 10/2/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs121908539?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29